TNFRSF1B and lung carcinoma: These findings are further supported by the observation that the levels of TNFR2 expression in human lung cancer patients, which are up to 35% [106], correlate positively to a more advanced clinical stage, immune invasion, progressive metastasis, shorter survival time, and poor prognosis [106,108].